SN. Stock Overview
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Smith & Nephew plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£10.09 |
| 52 Week High | UK£13.17 |
| 52 Week Low | UK£9.59 |
| Beta | 0.42 |
| 1 Month Change | -4.77% |
| 3 Month Change | -19.06% |
| 1 Year Change | -1.61% |
| 3 Year Change | -33.50% |
| 5 Year Change | -28.58% |
| Change since IPO | 525.10% |
Recent News & Updates
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price
Sep 11
Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet
Aug 19Recent updates
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price
Sep 11Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet
Aug 19Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital
Jul 17Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate
Jun 11Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly
May 09Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends
Apr 09Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)
Feb 09We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt
Nov 21Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)
Nov 08Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price
Oct 26These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well
Aug 11There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital
Jul 28Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price
Jun 26Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital
Apr 29These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Safely
Mar 26Earnings Beat: Smith & Nephew plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 24Smith & Nephew's (LON:SN.) Returns On Capital Not Reflecting Well On The Business
Jan 25Are Investors Undervaluing Smith & Nephew plc (LON:SN.) By 30%?
Dec 02Smith & Nephew (LON:SN.) Might Be Having Difficulty Using Its Capital Effectively
Oct 23Smith & Nephew (LON:SN.) Could Easily Take On More Debt
Oct 09A Look At The Intrinsic Value Of Smith & Nephew plc (LON:SN.)
Aug 22Be Wary Of Smith & Nephew (LON:SN.) And Its Returns On Capital
Jun 09Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet
May 25A Look At The Intrinsic Value Of Smith & Nephew plc (LON:SN.)
May 10Shareholder Returns
| SN. | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -4.1% | -2.2% | -1.8% |
| 1Y | -1.6% | -4.4% | 4.6% |
Return vs Industry: SN. matched the UK Medical Equipment industry which returned -1.4% over the past year.
Return vs Market: SN. underperformed the UK Market which returned 5.3% over the past year.
Price Volatility
| SN. volatility | |
|---|---|
| SN. Average Weekly Movement | 2.7% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: SN. is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: SN.'s weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1856 | 19,000 | Deepak Nath | https://www.smith-nephew.com |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.
Smith & Nephew plc Fundamentals Summary
| SN. fundamental statistics | |
|---|---|
| Market Cap | UK£8.80b |
| Earnings (TTM) | UK£179.71m |
| Revenue (TTM) | UK£4.41b |
48.9x
P/E Ratio2.0x
P/S RatioIs SN. overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SN. income statement (TTM) | |
|---|---|
| Revenue | US$5.35b |
| Cost of Revenue | US$1.58b |
| Gross Profit | US$3.77b |
| Other Expenses | US$3.55b |
| Earnings | US$218.00m |
Last Reported Earnings
Jul 01, 2023
Next Earnings Date
Feb 27, 2024
| Earnings per share (EPS) | 0.25 |
| Gross Margin | 70.41% |
| Net Profit Margin | 4.08% |
| Debt/Equity Ratio | 54.4% |
How did SN. perform over the long term?
See historical performance and comparisonDividends
3.1%
Current Dividend Yield150%
Payout RatioDoes SN. pay a reliable dividends?
See SN. dividend history and benchmarks| Smith & Nephew dividend dates | |
|---|---|
| Ex Dividend Date | Oct 05 2023 |
| Dividend Pay Date | Nov 01 2023 |
| Days until Ex dividend | 6 days |
| Days until Dividend pay date | 33 days |
Does SN. pay a reliable dividends?
See SN. dividend history and benchmarks